100 Clinical Results associated with Beijing Kailaipu Biotechnology Co., Ltd.
0 Patents (Medical) associated with Beijing Kailaipu Biotechnology Co., Ltd.
A Phase 1 Healthy Volunteer Dose Escalation to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Intravenous Human IgG1 Fc-F241A (NVG-2089) for the Treatment of CIDP (P4-11.015)
Author: Avery, Bill ; Kim, David ; Grimm, Karen ; Ratnayake, Anoshie ; Conley, Pamela ; Glicklich, Alan ; Leung, Joseph ; Bright, Jessica ; Mathew, Sneha ; Oguno, Bella ; Coffey, Yvonne ; Coffey, Greg
100 Deals associated with Beijing Kailaipu Biotechnology Co., Ltd.
100 Translational Medicine associated with Beijing Kailaipu Biotechnology Co., Ltd.